Navigation Links
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Date:11/26/2007

PRINCETON, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) appointed Patrick T. Higgins as Executive Vice President, Marketing & Sales, responsible for coordinating the global product launch and marketing activities for Pharmasset's drug candidates. Mr. Higgins, who has served as a consultant to Pharmasset since 2006, was recently Vice President, Sales & Marketing, Virology at Hoffmann-LaRoche, Inc. His areas of expertise include hepatology, HIV and cytomegalovirus for transplant patients. Mr. Higgins was responsible for directing the development and implementation of marketing and sales plans for Roche's US hepatology franchise, including the global launch of Pegasys(R) and Copegus(R) for the treatment of chronic hepatitis C infection.

Mr. Higgins has over 25 years of pharmaceutical industry sales and marketing experience. Throughout his career, he has participated in a total of 13 product launches for antiviral, oncology, dermatologic and allergy indications. Prior to joining Roche, Mr. Higgins served in a variety of advertising, sales and marketing roles at Schering Corporation. He was instrumental in developing Schering's Oncology/Biotech group that launched Intron-A(R) (interferon alfa-2b) for the treatment of chronic hepatitis.

"I am delighted to join Pharmasset at this stage of its development," stated Mr. Higgins. "I see the same characteristics and potential in Pharmasset's science, drug candidates and people that I saw in both Roche and Schering prior to their successful product launches."

"Pharmasset intends to commercialize clevudine for the treatment of chronic hepatitis B infection," stated Schaefer Price, Pharmasset's President & CEO. "To accomplish this goal
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Pharmassets Underwriters Release Shares from Lock-Up
2. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
3. WorldHeart Appoints David Pellone Chief Financial Officer
4. Novo Nordisk Appoints New Leader of North American Business
5. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...;Preventing and Healing AIDS Through Our Inner Pha... is a result of multiple, repeated and chronic exp...ssor agents, which can be either chemical, physica... Oakland, CA (PRWEB) November ...gists, physicians, chemists and other scientists f...
(Date:11/8/2009)... the Western District of Pennsylvania award a Faye...for a medical malpractice case. Attorneys Thomas ... E. Crenney and Associates, LLC handled the case o...ainst the Uniontown Hospital. The woman had to ha...e 18. , Pittsburgh, PA(PR...
(Date:11/8/2009).../ -- USAction this evening hailed passage of the A...make health care more affordable for consumers, ho...cess to health care for millions of Americans thro...nd Harry Truman would be proud," said USAction Pro...ong our country,s proudest achievements. Today we ...
(Date:11/8/2009)...e Reform Bill ,, Critical legislation would s...cans ,, CHICAGO, Nov. 7 /PRNewswire-USNewswire...ives passed by a vote of 220-215, critical health ...care for seniors and end discrimination by insuran... of affordable health coverage. ,, The Afford...
(Date:11/7/2009).../ -- Karen Ignagni, President and CEO of America,s...wing statement today on House passage of H.R. 3962...ve health care reform, and we have contributed to ...f how health insurance is provided. Earlier this y...of pre-existing condition exclusions, no longer ba...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2
...ner-Walker Chooses Two Tampa Beneficiaries for Par... TAMPA, Fla., Dec. 1 The Joyner-Walker Foundatio... and the Judeo Christian Health Clinic, Inc. as th...ropriate that events like this give back to the ho...
...k of the sunlight-derived nutrient tied to increas...1 (HealthDay News) -- A lack of vitamin D, which ..., helps boost the risk of heart attacks and stroke...efe, director of preventive cardiology at the Mid ...
...TLANTA, Dec. 1, 2008 The Arthritis Foundation ann...rize for research in arthritis. The recipients, Dr...ge of Physicians and Dr. Michel Nussenzweig of Roc...cognized for his research in the development and f...
...RFAX, Va., Dec. 1 The Food Allergy & Anaphyla...Ph.D., as its new CEO, replacing Founder Anne Muno...brings to FAAN extensive knowledge of anaphylaxis,...ning for all Dey Pharmaceutical products, includin...
...y-needling, steroids effective against plantar fas... (HealthDay News) -- Italian researchers say they,...ment for the painful foot condition known as plant...rcent success rate in tackling a condition that af...
...XANDRIA, Va., Dec. 1 Today, more than 740 childre...ie each day due to HIV/AIDS. , , December ...ch to help people worldwide understand the impact ...alk about HIV as well as helping dispel the myths ...
Other Medicine News:Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2Health News:Vitamin D Vital for the Heart 2Health News:Vitamin D Vital for the Heart 3Health News:FAAN Names New CEO 2Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2
(Date:11/5/2009)...tCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a lead...regenerative healing, today reported financial res...9. ,, "During the third quarter of 2009, our fo...roducts MagniFuse(TM) Bone Graft, FacetLinx(TM) F...fting," said Sam Owusu-Akyaw, President and Chief ...
(Date:11/5/2009)...re-FirstCall/ -- Transcept Pharmaceuticals, Inc. (...y focused on the development and commercialization...erapeutic needs in the field of neuroscience, toda...nce with management to discuss third quarter 2009 ...at 5:00 p.m. Eastern Standard Time. Financial res...
(Date:11/5/2009)...RAY, Inc., the world,s 5th largest manufacturer of... that it has received 510(k) clearance from the US...D Vital blood glucose monitoring system. ,, The...ake available for distribution in early December, ...existing GLUCOCARD line of products, and will be i...
Breaking Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 2Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 3Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 4NHLBI stops study of pulmonary hypertension treatment in sickle cell patients 52966 1NHLBI stops study of pulmonary hypertension treatment in sickle cell patients 52966 2NHLBI stops study of pulmonary hypertension treatment in sickle cell patients 52966 3NHLBI stops study of pulmonary hypertension treatment in sickle cell patients 52966 4NHLBI stops study of pulmonary hypertension treatment in sickle cell patients 52966 5Fox Chase researchers uncover one force behind the MYC oncogene in many cancers 9398 1Fox Chase researchers uncover one force behind the MYC oncogene in many cancers 9398 2
...ATLANTA, May 27 The Centers for Disease Control a...y announced the launch of a three-year campaign to...aign will provide resources and educational tools ...s better prevent and manage treatment-related infe...apy are at a higher risk for infections, which can...
...New Mobility for Veterans, Service Members, Other ...of Veterans Affairs (VA) has announced a three-yea...allows those with severe limb loss to pick up a ke...example of how VA researchers are continually mode... artificial limbs to meet Veterans, lifestyle and ...
Other Medicine Technology:CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients 2VA Studies Advanced Prosthetic Arm 2
...e world's smallest dual-chamber pacemaker, provide...nology available, including the revolutionary AF S...ercially approved algorithm designed to suppress a...thm in the Identity pacemaker family is combined w...
IntelliVue Information Center
LabScheduler Version 3.0
...lation Catheters combines the safeguard of robust ...ling system of the CryoCor Cardiac Cryoablation Co...e ablation site. CryoCor's Cryoablation catheters ... lesions necessary to permanently disrupt cardiac ...
Medicine Products: